Stay updated with breaking news from Acelrx Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) had its price target trimmed by HC Wainwright from $8.00 to $5.00 in a research note issued to investors on Monday, MarketBeat reports. The brokerage currently has a buy rating on the specialty pharmaceutical company’s stock. HC Wainwright also issued estimates for AcelRx Pharmaceuticals’ FY2024 earnings at ($0.75) EPS, […]
AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) had its target price trimmed by HC Wainwright from $8.00 to $5.00 in a research report sent to investors on Monday morning, Marketbeat reports. The firm currently has a buy rating on the specialty pharmaceutical company’s stock. HC Wainwright also issued estimates for AcelRx Pharmaceuticals’ FY2024 earnings at ($0.75) […]
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX – Get Rating) – Investment analysts at Cantor Fitzgerald cut their FY2023 earnings estimates for AcelRx Pharmaceuticals in a research report issued on Monday, April 3rd. Cantor Fitzgerald analyst B. Folkes now expects that the specialty pharmaceutical company will post earnings per share of ($2.41) for the year, down from their […]
In this article, we discuss the 10 cheapest stocks with the biggest upside.
Hepion Pharmaceuticals (NASDAQ:HEPA – Get Rating) and AcelRx Pharmaceuticals (NASDAQ:ACRX – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, dividends, earnings and valuation. Profitability This table compares Hepion Pharmaceuticals and AcelRx Pharmaceuticals’ […]